Transmission of Hepatitis C Virus Infection Associated with Home Infusion Therapy for Hemophilla

Morbidity and Mortality Weekly Report

Volumn 46, Issue 26, 1997, Pages 597-599

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; HEPATITIS C ANTIBODY;

ARTICLE; CASE REPORT; DISEASE TRANSMISSION; HEMOPHILIA A; HEPATITIS C; HEPATITIS C VIRUS; HOME CARE; HUMAN; ISOLATION AND PURIFICATION; NEEDLESTICK INJURY; PRESCHOOL CHILD;

CHILD, PRESCHOOL; FACTOR VIII; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HOME NURSING; HUMANS; NEEDLESTICK INJURIES;

EID: 0031552533     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liv Dis 1995;15:5-14.
2. Kasper CK, Lusher JM, Transfusion Practices Committee. Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion 1993;33:422-34.
3. Bray GL, Gomperts ED, Courter S, et al. A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. Blood 1994;83:2428-35.
4. Lawrence J. Recombinate: viral safety and final product manufacturing testing and specifications. Ann Hematol 1994;68(suppl 3):S21-S24.
5. Smith PS, Levine PH. The benefits of comprehensive care of hemophilia: a five-year study of outcomes. Am J Public Health 1984;74:616-7.
6. Lobato MN, Oxtoby MJ, Augustyniak L, Caldwell MB, Wiley SD, Simonds RJ. Infection control practices in the home: a survey of households of HIV-infected persons with hemophilia. Infect Control Hosp Epidemiol 1996;17:721-5.
7. CDC. Human immunodeficiency virus transmission in household settings - United States. MMWR 1994;43:347,353-6.
8. CDC. HIV infection in two brothers receiving intravenous therapy for hemophilia. MMWR 1992;41:228-31.